vatalanib has been researched along with 1,4-naphthoquinone in 1 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (1,4-naphthoquinone) | Trials (1,4-naphthoquinone) | Recent Studies (post-2010) (1,4-naphthoquinone) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 320 | 0 | 171 |
| Protein | Taxonomy | vatalanib (IC50) | 1,4-naphthoquinone (IC50) |
|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.8575 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 5.915 | |
| Dual specificity protein phosphatase 1 | Mus musculus (house mouse) | 8.45 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 2.76 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.38 | |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 5 | |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for vatalanib and 1,4-naphthoquinone
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |